SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

GUIRAO-BRINGAS, Patricia  y  DIAZ-PEREZ, Gustavo. Atrofia cerebelosa y uso crónico de fenitoína: Revisión de la literatura y presentación de un caso clínico. Rev. chil. neuro-psiquiatr. [online]. 2012, vol.50, n.1, pp. 42-50. ISSN 0717-9227.  http://dx.doi.org/10.4067/S0717-92272012000100005.

    1. Shorvon SD. Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909-1958. Epilepsia 2009; 50 Suppl 3: 69-92. [ Links ]

    2. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30 (4): 389-99. [ Links ]

    3. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47 (7): 1094-120. [ Links ]

    4. Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008; 49 (9): 1491-503. [ Links ]

    5. Merritt HH, Putnam TJ. Sodium diphenyl hydantoinate in treatment of convulsive seizures :toxic symptoms and their prevention. Arch Neurol Psychiatry 1939; 42: 1053-8. [ Links ]

    6. Del Negro A, Dantas CD, Zanardi V, Montenegro MA, Cendes F. Dose-dependent relationship of chronic use of phenytoin and cerebellar atrophy in patients with epilepsy. Arq Neuropsiquiatr 2000; 58 (2A): 276-81. [ Links ]

    7. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 2007; 48 (7): 1223-44. [ Links ]

    8. Zuin DR, Neme R, Porta L, Vera J, López OL. Acute cerebellar atrophy caused by diphenylhydantoin intoxication resulting from drug interaction. Rev Neurol 2003; 36 (2): 195-6. [ Links ]

    9. Chow KM, Szeto CC. Cerebral atrophy and skull thickening due to chronic phenytoin therapy. CMAJ 2007; 176 (3): 321-3. [ Links ]

    10. Fonnum F, Lock EA. Cerebellum as a target for toxic substances. Toxicol Lett 2000; 112-113: 9-16. [ Links ]

    11. Ghatak NR, Santoso RA, McKinney WM. Cerebellar degeneration following long-term phenytoin therapy. Neurology 1976; 26 (9): 818-20. [ Links ]

    12. McLain LW Jr, Martin JT, Allen JH. Cerebellar degeneration due to chronic phenytoin therapy. Ann Neurol 1980; 7 (1): 18-23. [ Links ]

    13. Brostoff JM, Birns J, McCrea D. Phenytoin toxicity: an easily missed cause of cerebellar syndrome. J Clin Pharm Ther 2008; 33 (2): 211-4. [ Links ]

    14. Koller WC, Glatt SL, Perlik S, Huckman MS, Fox JH. Cerebellar atrophy demonstrated by computed tomography. Neurology 1981; 31 (4): 405-12. [ Links ]

    15. Luef G, Burtscher J, Kremser C, Birbamer G, Aichner F, Bauer G, et al. Magnetic resonance volumetry of the cerebellum in epileptic patients after phenytoin overdosages. Eur Neurol 1996; 36 (5): 273-7. [ Links ]

    16. Nanri K, Koizumi K, Mitoma H, Taguchi M, Ishiko T, Otsuka T, et al. Classification of cerebellar atrophy using voxel-based morphometry and SPECT with an easy Z-score imaging system. Intern Med 2010; 49 (6): 535-41. [ Links ]

    17. Kim S, Melhem ER. Does diffusion-tensor MR imaging provide accurate tracing of specific white matter tracts that correspond to actual anatomic and functional units in the central nervous system? Radiology 2008; 249 (3): 725-7. [ Links ]

    18. Lee SK, Mori S, Kim DJ, Kim SY, Kim SY, Chu M, et al. Diffusion tensor MRI and fiber tractography of cerebellar atrophy in phenytoin users. Epilepsia 2003; 44 (12): 1536-40. [ Links ]

    19. Tran T, Ross B, Lin A. Magnetic resonance spec-troscopy in neurological diagnosis. Neurol Clin 2009; 27 (1): 21-60. [ Links ]

    20. De Marcos FA, Ghizoni E, Kobayashi E, Li LM, Cendes F. Cerebellar volume and long-term use of phenytoin. Seizure 2003; 12 (5): 312-5. [ Links ]

    21. Tan EK, Chan LL, Auchus AP. Phenytoin cerebe-llopathy without epilepsy. Acta Neurol Scand 2001; 104 (1): 61-2. [ Links ]

    22. Crooks R, Mitchell T, Thom M. Patterns of cere-bellar atrophy in patients with chronic epilepsy: a quantitative neuropathological study. Epilepsy Res 2000; 41 (1): 63-73. [ Links ]

    23. Rapport RL 2nd, Shaw CM. Phenytoin-related cerebellar degeneration without seizures. Ann Neurol 1977; 2 (5): 437-9. [ Links ]

    24. Ney GC, Lantos G, Barr WB, Schaul N. Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. Arch Neurol 1994; 51 (8): 767-71. [ Links ]

    25. Kuruvilla T, Bharucha NE. Cerebellar atrophy after acute phenytoin intoxication. Epilepsia 1997; 38 (4): 500-2. [ Links ]

    26. Alioglu Z, Sari A, Velioglu SK. Ozmenoglu M. Cerebellar Atrophy Following Acute Phenytoin intoxication. J Neuroradiol 2000; 27: 52-5. [ Links ]

    27. Dam M. Number of Purkinje cells in patients with grand mal epilepsy treated with diphenylhydantoin. Epilepsia 1970; 11 (3): 313-20. [ Links ]

    28. Ohmori H, Ogura H, Yasuda M, Nakamura S, Hatta T, Kawano K, et al. Developmental neuro-toxicity of phenytoin on granule cells and Purkinje cells in mouse cerebellum. J Neurochem 1999; 72 (4): 1497-506. [ Links ]

    29. Masur H, Elger CE, Ludolph AC, Galanski M. Cerebellar atrophy following acute intoxication with phenytoin. Neurology 1989; 39 (3): 432-3. [ Links ]

    30. Ulug AM, Moore DF, Bojko AS, Zimmerman RD. Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. AJNR Am J Neuroradiol 1999; 20 (6): 1044-8. [ Links ]

    31. Moon WJ, Kim HJ, Roh HG, Oh J, Han SH. Diffusion tensor imaging and fiber tractography in Parry-Romberg syndrome. AJNR Am J Neuroradiol 2008; 29 (4): 714-5. [ Links ]

    32. Shin DH, Han BS, Kim HS, Lee PH. Diffusion tensor imaging in patients with essential tremor. AJNR Am J Neuroradiol 2008; 29 (1): 151-3. [ Links ]

    33. Kitamura K, Nakayama K, Kasaka S, Yamada E, Shimada H, Miki T, et al. Diffusion tensor Imaging of the cortico-ponto-cerebellar pathway in patients with adult-onset ataxic neurodegenerative disease. Neuroradiology 2008; 50 (4): 285-92. [ Links ]

    34. Adachi M, Kawanami T, Ohshima H, Hosoya T. Cerebellar atrophy attributed to cerebellitis in two patients. Magn Reson Med Sci 2005; 4 (2): 103-7. [ Links ]

    35. Van der Knaap MS, Arts WF, Garbern JY, Hedlund G, Winkler F, Barbosa C, et al. Cerebellar leuko-encephalopathy: most likely histiocytosis-related. Neurology 2008; 71 (17): 1361-7. [ Links ]

    36. Shorvon SD. Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009. Epilepsia 2009; 50 Suppl 3: 93-130. [ Links ]